Improve Outcomes with Diverse Datasets

Scalable and secure data collection, annotation, and chatbot translation services.

Get AI Now
Translations Memory Life Sci

Deploy high-performance AI products to improve patients’ quality of life

Life sciences organizations continue to amass enormous amounts of unstructured data sets. The complexity of these vast collections of data can prevent sponsors and other clinical companies from accessing operational and patient efficiencies offered by machine learning.

TransPerfect Life Sciences' AI/ML data services resolve the complexity and enable machine learning models by converting unstructured data to structured data, combining highly efficient human input with state-of-the-art tools and workflows so that the result is accurate and unbiased.

HIPAA-Compliant Data Collection and Annotation Built for Scale

Ensure better-balanced datasets across 200+ languages with our data collection and annotation services, without breaking the bank. Our labeling team is comprised of ground truth experts, meaning all data provided comes by direct observation/measurement. From audio to video and images to text, our platform provides a scalable content moderation solution in secure facilities on the cloud.

Chatbot Localization

An estimated 80% of standard queries can be answered by chatbots. Our end-to-end chatbot localization service ensures your stakeholders receive accurate, fast responses in their native language through collecting global patient prompts; categorizing said prompts into groups; and then running user tests for compliance, conceptual equivalence, and cultural appropriateness.

Learn More ›

The Latest Developments in Artificial Intelligence for Life Sciences

Benefits of our AI Platform, DataForce

  • Stronger, global, diverse datasets
  • Recruiting large volumes of resources at scale
  • Up to 80% reduction in timelines
  • Flexible integration capabilities with our platform or third party of your choice
  • Up to 1,000 annotators onboarded within weeks of project kick-off
  • Compliant with SSAE 16 SOC 2, ISO 27001, HIPAA, & GDPR

Enhance Internal Efficiencies While Improving Patients' Quality of Life

For data scientists, machine learning engineers, and product managers looking to deploy high-performance AI products in the healthcare industry, DataForce by TransPerfect is a market leader in scalable and secure data collection and annotation services. DataForce converts unstructured data to structured data, combining highly efficient human input with state-of-the-art tools and workflows so that the result is accurate and unbiased to ensure companies are at the front line of innovation in bringing treatments and solutions to the world.

Trusted by Life Sciences Organizations Big and Small

Join TransPerfect's community of over 1,000 life sciences organizations, including pharma, biotech, CROs, IRBs, and agencies.

20230124-lifesciences-resize-v3_0022_400x160px-hologic_logo.png
untitled_design_4.png
20230124-lifesciences-resize-v3_0016_400x160px-bayer_logo.png
20230124-lifesciences-resize-v3_0015_400x160px-merck_logo.png

Achieve Better Data and Smarter AI Today.

Schedule a Free Consult.

How did you hear about us?
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

News and Thought Leadership

Our subject-matter experts have in-depth understanding of the technological challenges, requirements, and goals for life sciences organizations.

XTalks | How MI, PV & Regulatory Collaborate on Signals, Labeling, Crisis Response and AI

Medical Information (MI), Pharmacovigilance (PV) and Regulatory Affairs (RA) each play distinct but deeply interconnected roles in ensuring that therapeutics are safe, accurately labeled and compliantly communicated to healthcare professionals and patients. Yet in practice, the boundaries between these functions are rarely clean; a safety signal surfaced through an MI inquiry can trigger a PV investigation, which in turn may prompt a label update, a Risk Management ...

XTalks | How MI, PV & Regulatory Collaborate on Signals, Labeling, Crisis Response and AI

LifeSci Talks COA Series | Nothing Remains the Same: Why Measures Have to Evolve

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with RJ Wirth, CEO and Consulting Psychometrician at Vector Psychometric Group, to talk about why the measures we rely on are living things rather than fixed artifacts. ...

Regulatory Considerations for Paper COA Translations | What You Need to Know

Collecting data for a global clinical trial on paper COAs or managing a mixed-mode study that combines both paper and electronic formats means satisfying multiple regulatory bodies before a single patient enrolls. None of these entities operate on the same timeline or...

When "How Does the Patient Feel?" Became a Regulatory Question

For decades, clinical trials were built around things you could measure with a machine: tumor shrinkage on a scan, laboratory values, and disease progression. These hard, objective endpoints were the backbone of drug approval. The patient's own account of how they felt,...

XTalks | eCOA: Has It Lived Up to the Promise? A Realistic Assessment for Today's Trials

Despite two decades of technological advancement, the debate between paper and electronic clinical outcome assessments (eCOA) remains unresolved. This webinar revisits the assumptions that continue to shape data collection strategies and examines whether current practice reflects ...

SSCPs Are Not Labeling: Compliant AI Processes for Reduced Cost & Turnaround

In this fireside chat, TransPerfect Medical Device's President Marc Miller sits down with Dr. Keith Morel, VP of Regulatory Compliance at Qserve, to unpack a critical question facing medical device manufacturers under MDR: can you reduce the translation review process for ...

Top 10 Pharma Company Overhauls Global COA Program,Cutting Costs by 33% and Errors to Near Zero

Inconsistent standards, stretched timelines, and limited visibility were straining a top 10 pharma company's COA program. Discover how TransPerfect Life Sciences' centralization strategy delivered 99.7% accuracy, 40% less PM oversight, and 33% cost savings across the ...